Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #35,501 to #35,550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Neoplastic meningitis cost-effectiveness of therapy (2 revisions)
  2. Neoplastic meningitis future or investigational therapies (2 revisions)
  3. Neoplastic meningitis secondary prevention (2 revisions)
  4. Neorickettsia (2 revisions)
  5. Neosalvarsan (2 revisions)
  6. Neovascularization (2 revisions)
  7. Nepenthes boschiana (2 revisions)
  8. Nepenthes distillatoria (2 revisions)
  9. Nephritic syndrome case study one (2 revisions)
  10. Nephrocalcinosis CT (2 revisions)
  11. Nephrocalcinosis historical perspective (2 revisions)
  12. Nephrocalcinosis overview (2 revisions)
  13. Nephrocalcinosis pathophysiology (2 revisions)
  14. Nephrogenic diabetes insipidus (patient information) (2 revisions)
  15. Nephrogenic diabetes insipidus history and symptoms (2 revisions)
  16. Nephrogenic diabetes insipidus laboratory findings (2 revisions)
  17. Nephrogenic diabetes insipidus natural history, complications and prognosis (2 revisions)
  18. Nephrogenic diabetes insipidus primary prevention (2 revisions)
  19. Nephron (2 revisions)
  20. Nepinalone (2 revisions)
  21. Nerve agent (2 revisions)
  22. Nessler's reagent (2 revisions)
  23. Netrin 1 (2 revisions)
  24. Network effect (2 revisions)
  25. Neural cell adhesion molecule (2 revisions)
  26. Neural tube defect (2 revisions)
  27. Neuralgia epidemiology and demographics (2 revisions)
  28. Neuralgia laboratory findings (2 revisions)
  29. Neuralgia other diagnostic studies (2 revisions)
  30. Neuregulin 3 (2 revisions)
  31. Neurobiology (2 revisions)
  32. Neuroblastoma primary prevention (2 revisions)
  33. Neuroblastoma secondary prevention (2 revisions)
  34. Neurocardiology (2 revisions)
  35. Neurochemistry (2 revisions)
  36. Neuroendocrine tumors other diagnostic studies (2 revisions)
  37. Neurofibrillary tangle (2 revisions)
  38. Neurofibroma future or investigational therapies (2 revisions)
  39. Neurofibromatosis type 1 echocardiography and ultrasound (2 revisions)
  40. Neurofibromatosis type 1 electrocardiogram (2 revisions)
  41. Neurofibromatosis type 1 interventions (2 revisions)
  42. Neurofibromatosis type 1 other diagnostic studies (2 revisions)
  43. Neurofibromatosis type 1 overview (2 revisions)
  44. Neurofibromatosis type 1 primary prevention (2 revisions)
  45. Neuroglycopenia history and symptoms (2 revisions)
  46. Neurogranin (2 revisions)
  47. Neuroimaging (2 revisions)
  48. Neuromarketing (2 revisions)
  49. Neuromedin B receptor (2 revisions)
  50. Neuromedin N (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)